Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing
Journal of the American College of Cardiology, 2017 Defibrillation testing (DT) does not improve shock efficacy or reduce the risk for arrhythmic death in patients undergoing routine transvenous implantable cardioverter-defibrillator (ICD) placement and is no longer compulsory for left pectoral transvenous ICDs [(1)][1]. The subcutaneous ICD (S-ICD)
Marc A, Miller +9 more
openaire +2 more sources
Implantable cardioverter-defibrillator utilization [PDF]
Europace, 2011 Following the recent publication of our article1 concerning the European paradox with regard to implantable cardioverter defibrillator (ICD) device utilization in Europe (markedly lower device utilization in Europe compared with the USA), which updated several previous reports,2,3 …
John, Camm, Seah, Nisam
openaire +2 more sources
Single-chamber Versus Dual-chamber Implantable Cardioverter Defibrillators: Do We Need Physiologic Pacing in The Course? [PDF]
, 2006 Background: Many patients with ICD receive different antiarrhythmic drugs (e.g. sotalol, amiodarone, β-blockers) because of ventricular or atrial tachycardias.
Buck, Thomas +4 more
core +2 more sources
EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring [PDF]
, 2014 Aim: Remote follow-up (FU) of implantable cardiac defibrillators (ICDs) allows for fewer in-office visits in combination with earlier detection of relevant findings. Its implementation requires investment and reorganization of care. Providers (physicians
Annemans, Lieven +17 more
core +3 more sources
Subcutaneous Implantable Cardioverter-Defibrillator [PDF]
Circulation, 2014 For nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead.
Philip M, Chang +2 more
openaire +2 more sources
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
Global Heart, 2022 Background and Objectives: Implantation of implantable cardioverter-defibrillators (ICD) has increased significantly over the past decade. However, limited data exist regarding practices and policies of ICD implantations in Kazakhstan.
Temirkhan Begisbayev +4 more
doaj +1 more source
Radiofrequency Ablation for Post Infarction Ventricular Tachycardia [PDF]
, 2004 Radiofrequency ablation has an important role in the management of post infarction ventricular tachycardia. The mapping and ablation of ventricular tachycardia (VT) is complex and technically challenging.
Nadurata, Voltaire, O’Donnell, David
core +2 more sources
The death of cost-minimization analysis? [PDF]
, 2001 Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by
Altman +21 more
core +2 more sources
Cardiovascular Implantable Electronic Device Therapies for Chronic Heart Failure
Cardiology Discovery. Cardiovascular implantable electronic devices (CIEDs) are essential in the management of chronic heart failure, which remains a major cause of morbidity and mortality despite guideline-directed medical therapy.
Le Zhu +5 more
doaj +1 more source
Sex difference in clinical outcome of patients with implantable cardioverter-defibrillator
Research in Cardiovascular Medicine, 2013 Background: Indications for the use of the Implantable Cardioverter-Defibrillator (ICD) have been greatly expanded in recent years, but the influence of sex on the efficacy of the ICD in eligible patients has still been remained unknown.
Neshat Nazari +4 more
doaj +1 more source